Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 9.1M | $5.8M | 0% | Dec 2025 |
|
| Bain Capital Life Sciences Investors | 7.4M | $4.7M | 61% | Dec 2025 |
|
| Frazier Life Sciences Management | 5.9M | $3.8M | 100% | Dec 2025 |
|
| Point72 Asset Management | 4.0M | $2.6M | 100% | Dec 2025 |
|
| Sio Capital Management | 2.1M | $1.4M | 100% | Dec 2025 |
|
| Stempoint Capital | 2.0M | $1.3M | 100% | Dec 2025 |
|
| Merck & Co | 1.5M | $950k | 0% | Dec 2025 |
|
| Vanguard Group | 1.3M | $804k | 0% | Dec 2025 |
|
| Empery Asset Management | 1.2M | $757k | 100% | Dec 2025 |
|
| Ghisallo Capital Management | 1.1M | $713k | 100% | Dec 2025 |
|
| AJU IB Investment | 668k | $428k | 0% | Dec 2025 |
|
| FMR | 512k | $328k | 0% | Dec 2025 |
|
| Citadel Advisors | 436k | $279k | 100% | Dec 2025 |
|
| Renaissance Technologies | 344k | $221k | 68% | Dec 2025 |
|
| Geode Capital Management | 329k | $211k | 0% | Dec 2025 |
|
| State Street Corporation | 186k | $119k | 14% | Dec 2025 |
|
| Velan Capital Investment Management | 170k | $109k | 100% | Dec 2025 |
|
| GSA Capital Partners | 148k | $95k | 100% | Dec 2025 |
|
| Stonepine Capital Management | 126k | $81k | 100% | Dec 2025 |
|
| Northern Trust | 67k | $43k | 0% | Dec 2025 |
|
| Two Sigma Investments | 62k | $40k | -29% | Dec 2025 |
|
| Bridgeway Capital Management | 56k | $36k | 0% | Dec 2025 |
|
| Jane Street | 42k | $27k | 100% | Dec 2025 |
|
| Hrt Financial | 32k | $20k | 29% | Dec 2025 |
|
| Mariner Wealth Advisors | 25k | $16k | 0% | Dec 2025 |
|
| LPL Financial | 21k | $13k | -32% | Dec 2025 |
|
| Raymond James Financial | 19k | $12k | 0% | Dec 2025 |
|
| XTX Topco | 17k | $11k | -77% | Dec 2025 |
|
| Dunhill Financial | 10k | $6.6k | 0% | Dec 2025 |
|
| Pinnacle Financial Group, LLC / IL | 10k | $6.4k | 0% | Dec 2025 |
|
| Investors Asset Management Of Georgia | 10k | $6.4k | 0% | Dec 2025 |
|
| BlackRock | 2.0k | $1.3k | 0% | Dec 2025 |
|
| Key FInancial | 830.00 | $531.034000 | 0% | Dec 2025 |
|
| Private Wealth Management Group | 310.00 | $198.989000 | 0% | Dec 2025 |
|
| UBS Group | 203.00 | $130.001200 | -99% | Dec 2025 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Sep 2025 | 329k | $277k |
| Trustees of Columbia University in the City of New York | Sep 2025 | 250k | $210k |
| Balyasny Asset Management | Sep 2025 | 199k | $168k |
| Two Sigma Securities | Sep 2025 | 32k | $27k |
| Two Sigma Advisers | Sep 2025 | 30k | $25k |
| SevenBridge Financial | Sep 2025 | 25k | $19k |
| Aptus Capital Advisors | Sep 2025 | 25k | $21k |
| Federation des caisses Desjardins du Quebec | Sep 2025 | 3.3k | $2.8k |